MA42914A - TRICYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER - Google Patents
TRICYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCERInfo
- Publication number
- MA42914A MA42914A MA042914A MA42914A MA42914A MA 42914 A MA42914 A MA 42914A MA 042914 A MA042914 A MA 042914A MA 42914 A MA42914 A MA 42914A MA 42914 A MA42914 A MA 42914A
- Authority
- MA
- Morocco
- Prior art keywords
- cancer
- treatment
- tricyclic compounds
- tricyclic
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1514018.9A GB201514018D0 (en) | 2015-08-07 | 2015-08-07 | Novel tricyclic compounds and their use in the treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
MA42914A true MA42914A (en) | 2018-08-01 |
Family
ID=54200421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA042914A MA42914A (en) | 2015-08-07 | 2016-08-05 | TRICYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER |
Country Status (12)
Country | Link |
---|---|
US (1) | US10881653B2 (en) |
EP (1) | EP3331883A1 (en) |
JP (1) | JP6545908B2 (en) |
KR (2) | KR102428549B1 (en) |
CN (1) | CN108026096A (en) |
AU (1) | AU2016307438B2 (en) |
CA (1) | CA2995075C (en) |
GB (1) | GB201514018D0 (en) |
MA (1) | MA42914A (en) |
MX (1) | MX2018001575A (en) |
RU (1) | RU2736501C2 (en) |
WO (1) | WO2017027358A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA51821A (en) * | 2018-02-12 | 2020-12-23 | Cinda Pharma Ab | THIOREDOXIN REDUCTASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER |
CR20210175A (en) | 2018-09-18 | 2021-06-01 | Nikang Therapeutics Inc | Fused tricyclic ring derivatives as src homology-2 phosphatase inhibitors |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7550458B2 (en) * | 2005-10-18 | 2009-06-23 | Bristol-Myers Squibb Company | Tricycloundecane compounds useful as modulators of nuclear hormone receptor function |
EP2062181A2 (en) * | 2006-08-28 | 2009-05-27 | Dan Theodorescu | Prediction of an agent's or agents' activity across different cells and tissue types |
PL219045B1 (en) | 2010-10-16 | 2015-03-31 | Inst Chemii Organicznej Polskiej Akademii Nauk | New esters of (acyloxymethyl) acrylamide, pharmaceutical compositions containing thereof and the use thereof |
-
2015
- 2015-08-07 GB GBGB1514018.9A patent/GB201514018D0/en not_active Ceased
-
2016
- 2016-08-05 EP EP16751126.0A patent/EP3331883A1/en not_active Withdrawn
- 2016-08-05 CN CN201680046578.8A patent/CN108026096A/en active Pending
- 2016-08-05 CA CA2995075A patent/CA2995075C/en active Active
- 2016-08-05 RU RU2018107941A patent/RU2736501C2/en active
- 2016-08-05 WO PCT/US2016/045730 patent/WO2017027358A1/en active Application Filing
- 2016-08-05 KR KR1020207024002A patent/KR102428549B1/en active IP Right Grant
- 2016-08-05 AU AU2016307438A patent/AU2016307438B2/en not_active Ceased
- 2016-08-05 KR KR1020187006528A patent/KR20180032647A/en not_active IP Right Cessation
- 2016-08-05 US US15/750,819 patent/US10881653B2/en active Active
- 2016-08-05 MX MX2018001575A patent/MX2018001575A/en unknown
- 2016-08-05 MA MA042914A patent/MA42914A/en unknown
- 2016-08-05 JP JP2018526610A patent/JP6545908B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
RU2736501C2 (en) | 2020-11-17 |
GB201514018D0 (en) | 2015-09-23 |
RU2018107941A (en) | 2019-09-09 |
AU2016307438B2 (en) | 2019-07-11 |
RU2018107941A3 (en) | 2019-09-09 |
US20200113889A1 (en) | 2020-04-16 |
EP3331883A1 (en) | 2018-06-13 |
CN108026096A (en) | 2018-05-11 |
WO2017027358A1 (en) | 2017-02-16 |
CA2995075A1 (en) | 2017-02-16 |
MX2018001575A (en) | 2018-11-09 |
JP2018522948A (en) | 2018-08-16 |
US10881653B2 (en) | 2021-01-05 |
KR20200102529A (en) | 2020-08-31 |
KR102428549B1 (en) | 2022-08-03 |
AU2016307438A1 (en) | 2018-02-22 |
WO2017027358A8 (en) | 2017-05-11 |
JP6545908B2 (en) | 2019-07-17 |
KR20180032647A (en) | 2018-03-30 |
CA2995075C (en) | 2022-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA39960A (en) | IMIDAZO [4,5C] QUINOLINE-2-ONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER | |
FR22C1011I2 (en) | PRODRUGS OF FUMARATES AND THEIR USE FOR THE TREATMENT OF VARIOUS DISEASES | |
MA43163A (en) | CD80 EXTRACELLULAR POLYPEPTIDES AND THEIR USE IN CANCER TREATMENT | |
MA45122A (en) | CBP / EP300 HETEROCYCLIC INHIBITORS AND THEIR USE IN CANCER TREATMENT | |
MA52886A (en) | PURINONE COMPOUNDS AND THEIR USE IN CANCER TREATMENT | |
MA43135A (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | |
MA44225A (en) | SULPHONYLURIDES AND RELATED COMPOUNDS AND THEIR USE | |
MA49144A (en) | POLYTHERAPIES FOR THE TREATMENT OF CANCER | |
MA43283A (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | |
MA42420A (en) | VACCINES FOR THE TREATMENT AND PREVENTION OF CANCER | |
MA41449A (en) | POLYTHERAPIES FOR THE TREATMENT OF CANCERS | |
MA45613A (en) | POLYCYCLIC-CARBAMOYLPYRIDON COMPOUNDS AND THEIR PHARMACEUTICAL USE | |
MA41044A (en) | COMPOSITIONS AND METHODS OF USE FOR INCREASED IMMUNE RESPONSE AND CANCER TREATMENT | |
MA45709A (en) | SUBSTITUTED DIAZAHETERBICYCLIC COMPOUNDS AND THEIR USE | |
MA42915A (en) | PYRIDINES AND THEIR USE IN CANCER TREATMENT | |
MA47450A (en) | SULFINYLPYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER | |
MA41316A (en) | SEX DETERMINATION GENES AND THEIR USE IN REPRODUCTION | |
MA48637A (en) | POLYTHERAPIES FOR THE TREATMENT OF CANCER | |
MA50409A (en) | POLYTHERAPIES FOR THE TREATMENT OF CANCER | |
MA45675A (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | |
MA47408A (en) | CANCER TREATMENT | |
MA47452A (en) | HETEROCYCLYLSULFONYL SUBSTITUTION PYRIDINES AND THEIR USE IN CANCER TREATMENT | |
MA50440A (en) | IMIDAZOPYRIDINAMIDES SUBSTITUTED AND THEIR USE | |
MA47811A (en) | KIT INCLUDING AN ANTIBODY-DRUG IGF-1R CONJUGATE AND ITS USE FOR THE TREATMENT OF CANCER | |
MA45046A (en) | IRINOTECAN NANOLIPOSOMAL USED FOR THE TREATMENT OF SMALL CELL CANCER |